RxDoctor Payments Data

Erik Roberson

Neurology · Birmingham, ALNPI 1063437382

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,091 of the $48,832 with a category attached, or 96.4%. 4 manufacturers reported payments, led by Biogen at 57.1% of the total. Reporting peaked in 2019 at $27,887 and has fallen 90.5% since, to $2,656 in 2024.

$48,832in general payments, 2019–2025

Across 29 payments — averaging $1683.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$28K
  • Eli Lilly$21K
  • Eisai Inc.$90
  • Lexicon Pharmaceuticals, Inc.$15
$32,787in research payments, 2019–2025

Across 4 payments — averaging $8196.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$33K

What the payments were for

  • Consulting fees$47,09196%
  • Travel & lodging$1,4193%
  • Food & beverage$3221%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen17$27,887
Eli Lilly10$20,841
Eisai Inc.1$90
Lexicon Pharmaceuticals, Inc.1$15

How this compares

$48,832 in reported general payments places this provider in the 85th percentile of 255 neurology providers in Alabama.

See all neurology providers in Alabama

Medicare billing

Part B allowed, 2024
$14,933
Medicare patients
68
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →